Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

Contributed by: PR Newswire

Tags

Hansa-Biopharma-AB

More Like This

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference

Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS

Hansa Biopharma to Attend Truist Securities BioPharma Symposium

Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome

Hansa Biopharma interim report January-March 2024

Hansa Biopharma Interim Report January-September 2023

Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Hansa Biopharma to host Q2 2024 interim results conference call